Avina-Zubieta JA[au] - Search Results

Year	Number of Results
1994	1
1995	2
1996	1
1997	3
1998	2
1999	2
2000	1
2002	2
2003	5
2004	1
2008	2
2011	1
2012	5
2013	4
2014	9
2015	10
2016	10
2017	11
2018	9
2019	11
2020	10
2021	12
2022	11

1

Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population.

Jorge A, McCormick N, Lu N, Zheng Y, Esdaile J, De Vera M, Choi H, Aviña-Zubieta JA. Jorge A, et al. Among authors: avina zubieta ja. Arthritis Care Res (Hoboken). 2021 Aug;73(8):1219-1223. doi: 10.1002/acr.24255. Epub 2021 Jul 7. Arthritis Care Res (Hoboken). 2021. PMID: 32407570 Free PMC article.

2

Challenges of Perceived Self-Management in Lupus.

Fortin PR, Da Costa D, Neville C, Julien AS, Rahme E, Haroun V, Singer W, Nimigon-Young J, Morrison AL, Eng D, Peschken CA, Vinet E, Hudson M, Smith D, Matsos M, Pope JE, Clarke AE, Keeling S, Avina-Zubieta JA, Rochon M. Fortin PR, et al. Among authors: avina zubieta ja. Arthritis Care Res (Hoboken). 2022 Jul;74(7):1113-1121. doi: 10.1002/acr.24542. Epub 2022 Apr 13. Arthritis Care Res (Hoboken). 2022. PMID: 33342087

3

Mortality trends in polymyositis and dermatomyositis: A general population-based study.

Li L, D'Silva KM, Lu N, Huang K, Esdaile JM, Choi HK, Aviña-Zubieta JA. Li L, et al. Among authors: avina zubieta ja. Semin Arthritis Rheum. 2020 Oct;50(5):834-839. doi: 10.1016/j.semarthrit.2020.08.009. Epub 2020 Aug 28. Semin Arthritis Rheum. 2020. PMID: 32896696

4

Approaches for estimating minimal clinically important differences in systemic lupus erythematosus.

Rai SK, Yazdany J, Fortin PR, Aviña-Zubieta JA. Rai SK, et al. Among authors: avina zubieta ja. Arthritis Res Ther. 2015 Jun 3;17(1):143. doi: 10.1186/s13075-015-0658-6. Arthritis Res Ther. 2015. PMID: 26036334 Free PMC article. Review.

5

Hydroxychloroquine Use and Cardiovascular Events Among Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Jorge A, Lu N, Choi H, Esdaile JM, Lacaille D, Avina-Zubieta JA. Jorge A, et al. Among authors: avina zubieta ja. Arthritis Care Res (Hoboken). 2021 Dec 23:10.1002/acr.24850. doi: 10.1002/acr.24850. Online ahead of print. Arthritis Care Res (Hoboken). 2021. PMID: 34941008

6

Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.

McCormick N, Marra CA, Aviña-Zubieta JA. McCormick N, et al. Among authors: avina zubieta ja. Curr Rheumatol Rep. 2017 Oct 30;19(11):72. doi: 10.1007/s11926-017-0698-9. Curr Rheumatol Rep. 2017. PMID: 29086172 Review.

7

Rheumatic manifestations of hematologic disorders.

Aviña-Zubieta JA, Galindo-Rodriguez G, Lavalle C. Aviña-Zubieta JA, et al. Curr Opin Rheumatol. 1998 Jan;10(1):86-90. doi: 10.1097/00002281-199801000-00013. Curr Opin Rheumatol. 1998. PMID: 9448995 Review.

8

Rheumatic manifestations of malignancy.

Aviña-Zubieta JA, Enkerlin HL, Galindo-Rodriguez G. Aviña-Zubieta JA, et al. Curr Opin Rheumatol. 1996 Jan;8(1):47-51. doi: 10.1097/00002281-199601000-00009. Curr Opin Rheumatol. 1996. PMID: 8867539 Review.

9

Persistent premature mortality gap in dermatomyositis and polymyositis: a United Kingdom general population-based cohort study.

D'Silva KM, Li L, Lu N, Ogdie A, Avina-Zubieta JA, Choi HK. D'Silva KM, et al. Among authors: avina zubieta ja. Rheumatology (Oxford). 2021 Jun 18;60(6):2653-2660. doi: 10.1093/rheumatology/keaa661. Rheumatology (Oxford). 2021. PMID: 33175975 Free PMC article.

10

A systematic review identifies valid comorbidity indices derived from administrative health data.

Yurkovich M, Avina-Zubieta JA, Thomas J, Gorenchtein M, Lacaille D. Yurkovich M, et al. Among authors: avina zubieta ja. J Clin Epidemiol. 2015 Jan;68(1):3-14. doi: 10.1016/j.jclinepi.2014.09.010. Epub 2014 Oct 31. J Clin Epidemiol. 2015. PMID: 25441702 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results